In vivo, EV-packaged, LMP1-activated CAFs increased tumor volume and increased the levels of premetastatic niche factors (fibronectin, S100A8, and VEGFR1) in lung and liver tissue [48]. The gene discussed is PDLIM7; the disease is neoplasm.